APA

Bapiro T. E., Hasler J. A., Ridderström M. & Masimirembwa C. M. (20021115). The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant. Potential implications for CYP2D6 phenotyping studies and the clinical use of CYP2D6 substrate drugs in some African populations. : Biochemical pharmacology.

Chicago

Bapiro Tashinga E, Hasler Julia A, Ridderström Marianne and Masimirembwa Collen M. 20021115. The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant. Potential implications for CYP2D6 phenotyping studies and the clinical use of CYP2D6 substrate drugs in some African populations. : Biochemical pharmacology.

Harvard

Bapiro T. E., Hasler J. A., Ridderström M. and Masimirembwa C. M. (20021115). The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant. Potential implications for CYP2D6 phenotyping studies and the clinical use of CYP2D6 substrate drugs in some African populations. : Biochemical pharmacology.

MLA

Bapiro Tashinga E, Hasler Julia A, Ridderström Marianne and Masimirembwa Collen M. The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant. Potential implications for CYP2D6 phenotyping studies and the clinical use of CYP2D6 substrate drugs in some African populations. : Biochemical pharmacology. 20021115.